- cafead Oct 14, 2020 at 06:12: PM
via With the U.S. working at a rapid clip to scale capacity for a range of COVID-19 vaccines and therapeutics, stateside companies are snagging big down payments on the taxpayers' dime. Now, the government is cutting a check to a former General Electric business to help chip in.
The Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA) has shelled out $31 million to Boston-area technology and solutions provider Cytiva to pitch in on COVID-19 vaccine-related components, including cell culture media and bioreactors.
article source
The Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA) has shelled out $31 million to Boston-area technology and solutions provider Cytiva to pitch in on COVID-19 vaccine-related components, including cell culture media and bioreactors.
article source